Greg is Chief Medical and Information Officer at PRA Health Sciences, a leading pharmaceutical service, healthcare data and contract research provider. Previously, he was President and Chief Medical Officer at Castle Creek Pharmaceuticals, founder and President of Elipdera Therapeutics at Moderna, and had leadership roles at McKinsey & Co., Quintiles, Inc., Proteostasis, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He was co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on the advisory boards of the National Tay Sachs and Allied Disease Foundation and the Partnership for Palliative Care.